Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Available (expanded access)

Conditions studied: STAT1 Gain-of-Function Disease

In brief

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Key facts

Study ID

NCT05561985

Run by

Incyte Corporation

Last updated by the study team

2026-06-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.